牛牛AI助理已提取核心訊息
Jin Medical International Ltd. has notified the United States Securities and Exchange Commission (SEC) of a delay in filing its Annual Report on Form 20-F for the period ended September 30, 2023. The company cited the delay in finalizing its financial statements and other disclosures as the reason for not meeting the original filing deadline, which has resulted in undue hardship and expense. Jin Medical International has stated that it expects to file the report no later than fifteen calendar days following the prescribed due date. The notification, signed by CEO Erqi Wang on January 31, 2024, also confirms that all other periodic reports required by the SEC have been filed and anticipates significant changes in the results of operations from the last fiscal year to be reflected in the upcoming earnings statements.
Jin Medical International Ltd. has notified the United States Securities and Exchange Commission (SEC) of a delay in filing its Annual Report on Form 20-F for the period ended September 30, 2023. The company cited the delay in finalizing its financial statements and other disclosures as the reason for not meeting the original filing deadline, which has resulted in undue hardship and expense. Jin Medical International has stated that it expects to file the report no later than fifteen calendar days following the prescribed due date. The notification, signed by CEO Erqi Wang on January 31, 2024, also confirms that all other periodic reports required by the SEC have been filed and anticipates significant changes in the results of operations from the last fiscal year to be reflected in the upcoming earnings statements.
金醫療國際有限公司已通知美國證券交易委員會（SEC），延遲提交截至2023年9月30日的20-F表年度報告。該公司指出，延遲完成財務報表和其他披露是未按原提交截止日期的原因，這導致了不必要的困難和開支。Jin Medical International表示，預計將在規定的截止日期後的十五個日曆日內提交報告。該通知由首席執行官王爾奇於2024年1月31日簽署，還證實了美國證券交易委員會要求的所有其他定期報告均已提交，預計與上一財年相比經營業績的重大變化將反映在即將發佈的收益報表中。
金醫療國際有限公司已通知美國證券交易委員會（SEC），延遲提交截至2023年9月30日的20-F表年度報告。該公司指出，延遲完成財務報表和其他披露是未按原提交截止日期的原因，這導致了不必要的困難和開支。Jin Medical International表示，預計將在規定的截止日期後的十五個日曆日內提交報告。該通知由首席執行官王爾奇於2024年1月31日簽署，還證實了美國證券交易委員會要求的所有其他定期報告均已提交，預計與上一財年相比經營業績的重大變化將反映在即將發佈的收益報表中。
有用
沒用
